MarketResearchReports.Biz

Global Thermal Flowmeter Market to Grow at a CAGR of 5.79 Percent over the Period 2015-2019

LogoAbout Thermal Flowmeters

Global Surveillance and Security Equipment Market to Grow at a CAGR of 13.58 Percent over the Period 2015-2019

LogoSurveillance and security equipment is used for monitoring activities and behavior of individuals in areas such as airports, sea ports, railway stations, enterprises, educational institutions, retail stores, and banks that are susceptible to security threats. Proper surveillance in these areas helps reduce the occurrence of terrorist attacks and data theft.

Global Safes and Vaults Market to Grow at a CAGR of 5.32 Percent over the Period 2015-2019

LogoAbout Safes and Vaults

Market Overview: Acrostak (Schweiz) AG - Product Pipeline Analysis, 2015 Update

LogoAcrostak (Schweiz) AG (Acrostak) is a medical device manufacturer. The company develops, manufactures and distributes single use medical devices in the fields of interventional cardiology, interventional radiology and interventional oncology. Its interventional cardiology products includes grip, across CTP, across HP and genieinterventional radiology products include PTA balloon catheters designed to dilate and treat infrapopliteal arteries with local delivery of anti-restenotic drug. It also provides solutions to improve the treatment of peripheral arterial diseases (PAD). Acrostak is headquartered in Winterthur, Switzerland.

Industrial Report: Acoustic MedSystems, Inc. - Product Pipeline Analysis, 2015 Update

LogoAcoustic Medsystems, Inc. (AMS) is a medical equipments manufacturer. The company designs ultrasound and radiation therapy systems and instrumentation. Its products include radvision, a brachytherapy treatment planning system and theravision, an image-guided ultrasound ablation technology. It also offers products such as ablation and radiation treatment planning systems, delivery guidance software and systems, and high intensity needle-based and catheter-based interventional devices for thermal ablative therapy. AMS provides patient-specific planning, imaging, implants and applicator device alignment for treating cancer using radioactive seed implants and HDR afterloader devices, 2D and 3D anatomy, dose visualizations and post treatment seed localization. AMS is headquartered in Savoy, Illinois, the US.

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2015 in Pharmaceuticals

LogoGlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for January 2015 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in January 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Recent Release: Roche Diagnostics International Ltd - Product Pipeline Analysis, 2015 Update

LogoRoche Diagnostics International Ltd. (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devicesanalyzers, blood glucose meterslaboratory information, workflow and data management softwareand instruments and reagents for life science research. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. It has operations in the Americas, Asia Pacific, Africa, the Middle East and Europe. Roche Diagnostics manages all the central functions of the Diagnostics business of F. Hoffmann-La Roche Ltd. and is headquartered in Rotkreuz, Switzerland.

Research and Markets: LifeScan, Inc - Product Pipeline Analysis, 2015 Update

LogoLifeScan, Inc. (LifeScan) is a blood glucose monitoring company. The company undertakes the development, manufacture and marketing of blood glucose monitoring systems for home and hospital use. LifeScan's product portfolio includes blood glucose meters, testing strips and control solutions, lancing devices, diabetes management software and tools and accessories. It also provides support services. The company has manufacturing facilities in Puerto Rico and Scotland. LifeScan markets its products across Africa, Asia Pacific, Eastern Europe, Europe, Latin America, the Middle East and North America. The company is a subsidiary of Johnson & Johnson. LifeScan is headquartered in Wayne, Pennsylvania, the US.

Research Announces: Abbott Medical Optics, Inc. - Product Pipeline Analysis, 2015 Update

LogoAbbott Medical Optics, Inc. (Abbott Medical), formerly Advanced Medical Optics, Inc., is an ophthalmic devices company. It carries out the discovery and delivery of vision technologies that optimize the quality of life for people. The company focuses on developing a broad suite of technologies and devices to address a wide range of vision disorders. It is a global specialist in the development, manufacture and marketing of surgical medical devices for eye and eye care products. Abbott Medical offers its products in three categories, namely, cataract, refractive and corneal products. The company operates in AmericasEurope, Africa and the Middle Eastand Asia-Pacific. It markets products in approximately 60 countries. Abbott Medical is a subsidiary of Abbott Laboratories and is headquartered in California, the US.The company focuses on thoughtfully designed innovations, based on extensive consumer insight, to meet the needs of patients and ophthalmologists. Abbott Medical envisages establishing its position through the development of innovative products and services and enhancement of existing ones, internal development, strong partner relationships and strategic collaborations.